Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lung cancer survival improved with new radiotherapy technique

July 21, 1997

Medeva acquires license to anthracycline derivative for the treatment of bladder cancer

July 21, 1997

GeneMedicine receives quarterly payment from Corange in anticancer gene medicine collaboration

July 21, 1997

Novel inhibitors of geranylgeranylation from Baldacci

July 21, 1997

ICN describes antisense oligonucleotides for IL-8 and/or IL-8R

July 21, 1997

Spotlight on new drugs for cancer

July 21, 1997

Onyx reports on clinical progress of ONYX-015

July 18, 1997

The Liposome Company reacquires TLC-D-99 rights from Pfizer, reports phase III results

July 18, 1997

Japanese approval for Taxol

July 18, 1997

Sankyo discovers gelatinase inhibitors

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...